These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 22515801

  • 1. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
    Luengratsameerung S, Panyakhamlerd K, Treratanachat S, Taechakraichana N.
    Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801
    [Abstract] [Full Text] [Related]

  • 2. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S, Nunthapisud P, Trivijitsilp P, Sentrakul P, Dusitsin N.
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women.
    Prestwood KM, Gunness M, Muchmore DB, Lu Y, Wong M, Raisz LG.
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2197-202. PubMed ID: 10852452
    [Abstract] [Full Text] [Related]

  • 4. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B, Nachtigall L, Plouffe L, Siddhanti S, Rosen A, Parsons A.
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [Abstract] [Full Text] [Related]

  • 5. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D.
    Anticancer Res; 2007 Sep; 27(4A):1853-62. PubMed ID: 17649784
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.
    Azizi G, Hansen A, Prestwood KM.
    Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800
    [Abstract] [Full Text] [Related]

  • 16. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB, Fontana A, Guastalla JP, Munoz F, Brun J, Delmas PD.
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.